1-10 of 10
Authors: Arturo Cesaro
Sort by
Journal Article
528 OUTCOMES IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH SGLT2-I: THE SGLT2-I AMI PROTECT REGISTRY
Pasquale Paolisso and others
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.404, https://doi.org/10.1093/eurheartjsupp/suac121.404
Published: 15 December 2022
Journal Article
1075 USE OF LIPID-LOWERING COMBINATION THERAPIES IN SANTORINI STUDY: EVIDENCE FROM ITALIAN COHORT
Arturo Cesaro and others
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.147, https://doi.org/10.1093/eurheartjsupp/suac121.147
Published: 15 December 2022
Journal Article
866 INFARCT SIZE, INFLAMMATORY BURDEN AND ADMISSION HYPERGLYCEMIA IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH SGLT2-INHIBITORS: A MULTICENTER INTERNATIONAL REGISTRY
Angelo Sansonetti and others
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.543, https://doi.org/10.1093/eurheartjsupp/suac121.543
Published: 15 December 2022
Journal Article
1134 IN-HOSPITAL ARRHYTHMIC BURDEN REDUCTION IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH SGLT2-INHIBITORS: INSIGHTS FROM THE SGLT2-I AMI PROTECT STUDY
Arturo Cesaro and others
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.504, https://doi.org/10.1093/eurheartjsupp/suac121.504
Published: 15 December 2022
Journal Article
555 ADHERENCE AND PERSISTENCE OF PCSK9 INHIBITORS IN CLINICAL PRACTICE: THE REAL-WORLD ITALIAN EXPERIENCE (AT-TARGET-IT STUDY)
Federica Marzano and others
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.706, https://doi.org/10.1093/eurheartjsupp/suac121.706
Published: 15 December 2022
Journal Article
Reduction of cerebrovascular and peripheral events with PCSK9 inhibitors: Does it just depend on the lowering of the low-density lipoprotein?
Arturo Cesaro and others
European Heart Journal Supplements, Volume 24, Issue Supplement_I, November 2022, Pages I34–I37, https://doi.org/10.1093/eurheartjsupp/suac099
Published: 12 November 2022
Journal Article
596 Multidisciplinary in-depth investigation in a young athlete suffering from syncope caused by myocardial bridge
Mariarita Brancaccio and others
European Heart Journal Supplements, Volume 23, Issue Supplement_G, December 2021, suab144, https://doi.org/10.1093/eurheartj/suab144
Published: 08 December 2021
Journal Article
760 Prevalence of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the start-antiplatelet registry
Arturo Cesaro and others
European Heart Journal Supplements, Volume 23, Issue Supplement_G, December 2021, suab140.013, https://doi.org/10.1093/eurheartj/suab140.013
Published: 08 December 2021
Journal Article
341 Observational multicentre study on effectiveness and tolerability of Alirocumab in real world, the OMERO study: interim data from the first 699 patients
Alberico Luigi Catapano and others
European Heart Journal Supplements, Volume 23, Issue Supplement_G, December 2021, suab148.005, https://doi.org/10.1093/eurheartj/suab148.005
Published: 08 December 2021
Journal Article
785 Sodium–glucose cotransporter 2 inhibitors in real-life patients at high cardiovascular risk
Arturo Cesaro and others
European Heart Journal Supplements, Volume 23, Issue Supplement_G, December 2021, suab131.002, https://doi.org/10.1093/eurheartj/suab131.002
Published: 08 December 2021
Advertisement
Advertisement